Material Group inc. Logo

Material Group inc.

A professional services firm offering PR consulting, marketing, and brand strategy.

156A | T

Overview

Corporate Details

ISIN(s):
JP3869850002
LEI:
Country:
Japan
Address:
港区赤坂一丁目12番32号アーク森ビル35階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Material Group Inc. is a professional services firm that offers comprehensive marketing and communications support, with a core focus on PR consulting. The company operates as a collective of specialized businesses that collaborate to provide tailored solutions for a diverse range of clients. Its services include brand strategy analysis, market research, and business marketing, all aimed at maximizing the potential of clients' brands, products, and services. In March 2024, Material Group was listed on the Tokyo Stock Exchange's Growth Market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-09 08:39
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.7 KB
2025-05-15 10:10
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.3 KB
2025-04-14 08:31
Regulatory News Service
確認書
Japanese 8.1 KB
2025-04-14 08:30
Interim Report
半期報告書-第12期(2024/09/01-2025/08/31)
Japanese 197.5 KB
2024-12-02 07:32
Post-Annual General Meeting Information
訂正臨時報告書
Japanese 32.7 KB
2024-11-28 07:32
Post-Annual General Meeting Information
臨時報告書
Japanese 23.1 KB
2024-11-28 07:31
Governance Information
内部統制報告書-第11期(2023/09/01-2024/08/31)
Japanese 23.6 KB
2024-11-28 07:31
Registration Form
確認書
Japanese 8.1 KB
2024-11-28 07:30
Annual Report
有価証券報告書-第11期(2023/09/01-2024/08/31)
Japanese 1.9 MB
2024-11-27 07:30
Earnings Release
臨時報告書
Japanese 18.4 KB
2024-07-12 08:01
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-07-12 08:01
Quarterly Report
四半期報告書-第11期第3四半期(2024/03/01-2024/05/31)
Japanese 144.7 KB
2024-04-30 08:14
Major Shareholding Notification
臨時報告書
Japanese 20.3 KB
2024-04-12 08:03
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-04-12 08:02
Quarterly Report
四半期報告書-第11期第2四半期(2023/12/01-2024/02/29)
Japanese 168.5 KB

Automate Your Workflow. Get a real-time feed of all Material Group inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Material Group inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Material Group inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.